New CLL Treatment Paradigm Nears In EU For AbbVie
EMA OKs New Indication For Venclyxto
The first chemotherapy-free, first-line treatment for chronic lymphocytic leukemia where dosing can be completed in one year has received the thumbs up by the European Medicines Agency.
You may also be interested in...
A plethora of new drugs moved closer to the EU market this week after the European Medicines Agency recommended that they should be approved.
Three companies are set to learn this week whether the European Medicines Agency will fast track its review of their soon-to-be-filed EU marketing applications.
Janssen and AstraZeneca are among a raft of companies that might this week find out whether the European Medicines Agency will recommend approval of their products for expanded therapeutic indications.